Results 181 to 190 of about 50,615 (267)

Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium. [PDF]

Biomed Res Int, 2018
Hamelmann E.
europepmc   +1 more source

Long-acting muscarinic antagonist and long-acting β₂-agonist combination for the treatment of maintenance therapy-naïve patients with chronic obstructive pulmonary disease: a narrative review. [PDF]

Ther Adv Respir Dis
Buhl R, Miravitlles M, Anzueto A, Brunton S.   +3 more
europepmc   +1 more source

Ethylatropine Bromide as a Peripherally Restricted Muscarinic Antagonist. [PDF]

ACS Chem Neurosci, 2017
Rojas A, Ganesh T, Walker A, Dingledine R.   +3 more
europepmc   +1 more source

Comparisons of Efficacy and Safety between Triple (Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist) Therapies in Chronic Obstructive Pulmonary Disease: Systematic Review and Bayesian Network Meta-Analysis.

Respiration, 2021
Lee HW, Kim HJ, Jang EJ, Lee CH.
europepmc   +1 more source

Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD. [PDF]

Int J Chron Obstruct Pulmon Dis, 2018
D'Urzo AD, Kardos P, Wiseman R.
europepmc   +1 more source

Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate. [PDF]

Chronic Obstr Pulm Dis, 2019
Mahler DA, Ohar JA, Barnes CN, Moran EJ, Pendyala S, Crater GD.   +5 more
europepmc   +1 more source

Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease. [PDF]

Drugs Real World Outcomes, 2020
Roberts MH, Mapel DW, Petersen H.
europepmc   +1 more source

A Muscarinic Antagonist Reduces Airway Inflammation and Bronchoconstriction Induced by Ambient Particulate Matter in a Mouse Model of Asthma. [PDF]

Int J Environ Res Public Health, 2018
Kurai J, Watanabe M, Sano H, Iwata K, Hantan D, Shimizu E.   +5 more
europepmc   +1 more source

Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease. [PDF]

Ann Pharmacother, 2019
Pleasants RA.
europepmc   +1 more source

Anxiolytic and antidepressant effects of astaxanthin: behavioral and mechanistic insights in a rat model. [PDF]

Front Pharmacol
Ranjbari M, Fakhri S, Abbaszadeh F, Kiani A, Mohammadi-Noori E, Echeverría J.   +5 more
europepmc   +1 more source